MedPath

ALLERGY RELIEF NASAL SPRAY

ALLERGY RELIEF NASAL SPRAY

Approved
DIN Number

02460475

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02460475
AIG Number0124685001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R01AD08 FLUTICASONE
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLUTICASONE PROPIONATEActive
Strength: 50 MCG / ACT
Monograph: FLUTICASONE PROPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.